NHS National Pharmaceuticals Transition 2022_1

NHS England and NHS ImprovementcontractContracts Finder ↗Ref CF-1007100D0O000000rwimUAASME suitablecomplete

Estimated value

£39.6m

Awarded value

£39.6m

Awarded 18 Jul 2022

Suppliers

1

Lots

1

1 awarded

Published

12 Aug 2022

Deadline 21 Apr 2022

Awarded suppliers· 1 supplier

Awarded 18 Jul 2022 · Contract period 28 Jul 2022 — 30 May 2024

Award value

£39.6m

1

CP

Celix Pharma Ltd.,Mylan,Kent Pharma Ltd,Accord-UK Ltd,Pfizer Ltd,Norgine Pharmaceuticals Limited,Amarox Limited,Teva UK Limited,Dr.Reddy's Laboratories (UK) Limited,Napp Pharmaceuticals Ltd,Morningside Pharmaeuticals,B. Braun Medical Limited,Roma Pharmaceuticals Limited,Sandoz Ltd,Selective Supplies Ltd.,FLYNN PHARMA LTD,Neon Healthcare Ltd,Flexipharm Austrading Limited,Tillomed Laboratories ltd,Sintetica Ltd,Zentiva Pharma UK Ltd,Mercury Pharmaceuticals Limited,Glenmark Pharmaceuticals Europe Limited,Intrapharm Laboratories Ltd,Aspen Pharmacare UK Limited,Ranbaxy UK,Wockhardt UK Limited,medac Pharma LLP,Roche Products Ltd,Clinigen Healthcare Limited,Piramal Critical care Limited,Milpharm Ltd/aurobinbdo,Chiesi Limited,Consilient Health Ltd,Fresenius Kabi Limited,Alturix,Day Lewis Medical Ltd,Relonchem Ltd,ennogen healthcare ltd,Panpharma UK Limited,Macure Pharma ApS,Rosemont Pharmaceuticals Limited